Global Bone and Joint Health Supplements Market Growth (Status and Outlook) 2023-2029
Bone and Joint Health Supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid, for bone and joint.
This report focuses on the 2C market.
LPI (LP Information)' newest research report, the “Bone and Joint Health Supplements Industry Forecast” looks at past sales and reviews total world Bone and Joint Health Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Bone and Joint Health Supplements sales for 2023 through 2029. With Bone and Joint Health Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone and Joint Health Supplements industry.
This Insight Report provides a comprehensive analysis of the global Bone and Joint Health Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bone and Joint Health Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone and Joint Health Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone and Joint Health Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone and Joint Health Supplements.
The global Bone and Joint Health Supplements market size is projected to grow from US$ 3123.7 million in 2022 to US$ 4152.2 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.
Global key players of Bone and Joint Health Supplements include Nature's Bounty, GSK-Pfizer, By-Health, Nature Made and Schiff, etc. Top five players occupy for a share about 38%. North America is the largest market, with a share about 38%, followed by Asia-Pacific and Europe. In terms of product, Calcium and Vitamin D3 is the largest segment, with a share over 59%. In terms of application, Below 12 Years Old is the largest market, with a share over 29%.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone and Joint Health Supplements market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Calcium and Vitamin D3
Omega-3 (Fish Oil)
Glucosamine and Chondroitin
Magnesium
Collagen
Turmeric
Others
Segmentation by application
Below 12 Years Old
12-18 Years Old
19-49 Years Old
50-60 Years Old
Above 60 Years Old
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Swisse
GSK-Pfizer
A&Z Pharmaceutical
Amway (Nutrilite)
Shanxi Zhendong Pharmaceutical
Nature Made
By-Health
Harbin Pharmaceutical Group
Bayer
GNC Holdings
Bio Island
Nature's Bounty
High Change
Bluebonnet Nutrition
Schiff
Solgar
BioTrust Nutrition
Pure Encapsulations
NOW Foods
Blackmores
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook